The judgment will save taxpayers' money without hurting the pharma industry or R&D, write Achal Prabhala & Kajal Bhardwaj. In September 2007, Arun Kumar*, a serving officer in the Indian Army, was......
Global drugmakers, battered by recent intellectual property decisions in India, are girding for a landmark court ruling next week with broad consequences for their ability to sell lucrative......
Swiss pharma major Novartis AG has as many as 140 research projects, including new drug discovery and finding new uses for existing medicines, in various stages of clinical development. Paul......